Skip to main content
Top
Published in: Molecular Diagnosis & Therapy 1/2007

01-01-2007 | Original Research Article

RB1 Germ-Line Deletions in Argentine Retinoblastoma Patients

Authors: Cecilia Fernández, Karina Repetto, Viviana Dalamon, Fenanda Bergonzi, Veronica Ferreiro, Dr Irene Szijan

Published in: Molecular Diagnosis & Therapy | Issue 1/2007

Login to get access

Abstract

Background: Retinoblastoma (RB) is a malignant tumor originating in the retinal cell precursors and can be presented as a unilateral or bilateral form in childhood (one or both eyes affected). Development of this tumor is caused by mutations in the RB1 gene on chromosome 13ql4; the first mutation may occur in the germ line (hereditary RB) or in somatic cells (non-hereditary RB). The hereditary form of RB is transmitted with a high penetrance to offspring (90%). Because early diagnosis is necessary for implementing effective treatment and preserving vision, it is important to identify the mutations in the affected family.
Aim: The aim of this study was to identify large and small RB1 germ-line mutations and to correlate them with the RB phenotype.
Methods: Constitutional RB1 gene gross deletions were studied in 40 patients with bilateral or unilateral familial RB by a segregation assay of four intragenic polymorphisms located in introns 1,4, 17, and 20 of the RB1 gene, along with fluorescence in situ hibridization (FISH) analysis. Small mutations were ascertained in a subgroup of ten patients by heteroduplex/sequence analysis of RB1-exons.
Results: In the course of our study, we have found three large deletions, which probably represent whole gene deletions, and two small deletions of 1bp in length. One large deletion was found in a family with several members affected. This represents a rare case of familial RB, which is usually caused by small mutations. Phenotype analysis of the family revealed a low penetrance inheritance, with an ‘affected eyes: number of mutation-carriers’ ratio of ≈1.0, whereas this ratio in families with small loss-of-function mutations is 1.5–2.0.
Conclusions: Our results emphasize the usefulness of a combined methodology that includes segregation of polymorphisms, FISH, and heteroduplex/sequence analyses for detection of gross and small DNA rearrangements in familial and sporadic RB. Identification of mutations in sporadic cases is important for risk-assessment in patients’ relatives. The degree of penetrance in the inheritance of RB not only depends on the occurrence of the second mutation in the RB1 gene but also on the extent of inactivation of the first mutation.
Literature
2.
go back to reference Knudson AG. Mutation and cancer: statistical study on retinoblastoma. Proc Natl Acad Sci U S A 1971; 68: 820–3PubMedCrossRef Knudson AG. Mutation and cancer: statistical study on retinoblastoma. Proc Natl Acad Sci U S A 1971; 68: 820–3PubMedCrossRef
3.
go back to reference Friend SH, Bernards R, Rogelis S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–6PubMedCrossRef Friend SH, Bernards R, Rogelis S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–6PubMedCrossRef
5.
go back to reference Valverde JR, Alonso J, Palacios I, et al. RB1 gene mutation up-date: a meta-analysis based on 932 reported mutations available in a searchable database. BMC Genetics 2005; 6: 53PubMedCrossRef Valverde JR, Alonso J, Palacios I, et al. RB1 gene mutation up-date: a meta-analysis based on 932 reported mutations available in a searchable database. BMC Genetics 2005; 6: 53PubMedCrossRef
6.
go back to reference Richter S, Vandezande K, Chen N, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003; 72: 253–69PubMedCrossRef Richter S, Vandezande K, Chen N, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003; 72: 253–69PubMedCrossRef
7.
8.
go back to reference Szijan I, Lohmann DR, Parma DL, et al. Identification of RBI germline mutations in Argentine families with sporadic bilateral retinoblastoma. J Med Genet 1995; 32: 475–9PubMedCrossRef Szijan I, Lohmann DR, Parma DL, et al. Identification of RBI germline mutations in Argentine families with sporadic bilateral retinoblastoma. J Med Genet 1995; 32: 475–9PubMedCrossRef
9.
go back to reference Dalamon V, Surace E, Borelina D, et al. Detection of mutations in Argentine retinoblastoma patients by segregation of polymorphisms, exon analysis and cytogenetic test. Ophthalmic Res 2001; 33: 336–9PubMedCrossRef Dalamon V, Surace E, Borelina D, et al. Detection of mutations in Argentine retinoblastoma patients by segregation of polymorphisms, exon analysis and cytogenetic test. Ophthalmic Res 2001; 33: 336–9PubMedCrossRef
10.
go back to reference Dalamon V, Surace E, Giliberto F, et al. Detection of germline mutations in Argentine retinoblastoma patients: low and full penetrance retinoblastoma caused by the same germline truncating mutation. J Biochem Mol Biol 2004; 37: 246–53PubMedCrossRef Dalamon V, Surace E, Giliberto F, et al. Detection of germline mutations in Argentine retinoblastoma patients: low and full penetrance retinoblastoma caused by the same germline truncating mutation. J Biochem Mol Biol 2004; 37: 246–53PubMedCrossRef
11.
go back to reference Bookstein R, Lai C, To H, et al. PCR-based detection of a polymorphic BamHI site in intron 1 of the human retinoblastoma (RB) gene. Nucl Acids Res 1992; 18: 1666CrossRef Bookstein R, Lai C, To H, et al. PCR-based detection of a polymorphic BamHI site in intron 1 of the human retinoblastoma (RB) gene. Nucl Acids Res 1992; 18: 1666CrossRef
12.
go back to reference McGee Tl, Cowley GS, Yandell DW, et al. Detection of the XbaI RFLP within the retinoblastoma locus by PCR. Nucl Acids Res 1990; 18: 207PubMedCrossRef McGee Tl, Cowley GS, Yandell DW, et al. Detection of the XbaI RFLP within the retinoblastoma locus by PCR. Nucl Acids Res 1990; 18: 207PubMedCrossRef
13.
go back to reference Toguchida J, McGee TL, Paterson C, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 1993; 17: 535–43PubMedCrossRef Toguchida J, McGee TL, Paterson C, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 1993; 17: 535–43PubMedCrossRef
14.
go back to reference Brandt B, Greger V, Yandell D, et al. A simple and nonradioactive method for detecting the Rb1.20 DNA polymorphism in the retinoblastoma gene. Am J Hum Genet 1992; 51: 1450–1PubMed Brandt B, Greger V, Yandell D, et al. A simple and nonradioactive method for detecting the Rb1.20 DNA polymorphism in the retinoblastoma gene. Am J Hum Genet 1992; 51: 1450–1PubMed
15.
go back to reference Arbetman A, Abdala M, Fandiño A, et al. Clinical, cytogenetic and molecular testing of Argentine patients with retinoblastoma. J AAPOS 1998; 2: 102–7PubMedCrossRef Arbetman A, Abdala M, Fandiño A, et al. Clinical, cytogenetic and molecular testing of Argentine patients with retinoblastoma. J AAPOS 1998; 2: 102–7PubMedCrossRef
16.
go back to reference Lohmann DR, Brandt B, Hopping W, et al. Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum Genet 1994; 94: 349–54PubMedCrossRef Lohmann DR, Brandt B, Hopping W, et al. Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum Genet 1994; 94: 349–54PubMedCrossRef
17.
go back to reference den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109: 121–4CrossRef den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109: 121–4CrossRef
18.
go back to reference Sippel KC, Fraioli RE, Smith GD, et al. Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counselling. Am J Hum Genet 1998; 62: 610–9PubMedCrossRef Sippel KC, Fraioli RE, Smith GD, et al. Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counselling. Am J Hum Genet 1998; 62: 610–9PubMedCrossRef
19.
go back to reference Kloss K, Wahrisch P, Greger V, et al. Characterization of deletions at the retinoblastoma locus in patients with bilateral retinoblastoma. Am J Med Genet 1991; 39: 196–200PubMedCrossRef Kloss K, Wahrisch P, Greger V, et al. Characterization of deletions at the retinoblastoma locus in patients with bilateral retinoblastoma. Am J Med Genet 1991; 39: 196–200PubMedCrossRef
20.
go back to reference Houdayer C, Gauthier-Villars M, Laugé A, et al. Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Hum Mutat 2004; 23: 193–202PubMedCrossRef Houdayer C, Gauthier-Villars M, Laugé A, et al. Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Hum Mutat 2004; 23: 193–202PubMedCrossRef
21.
go back to reference Albrecht P, Ansperger-Reschen B, Schüler A, et al. Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression. Hum Mutat 2005; 26: 437–45PubMedCrossRef Albrecht P, Ansperger-Reschen B, Schüler A, et al. Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression. Hum Mutat 2005; 26: 437–45PubMedCrossRef
22.
go back to reference DiCiommo D, Gallie BL, Bremner R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin Cancer Biol 2000; 10: 255–69PubMedCrossRef DiCiommo D, Gallie BL, Bremner R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin Cancer Biol 2000; 10: 255–69PubMedCrossRef
25.
go back to reference Wiggs J, Nordenskjöld M, Yandell D, et al. Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. New Engl J Med 1988; 318: 151–7PubMedCrossRef Wiggs J, Nordenskjöld M, Yandell D, et al. Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. New Engl J Med 1988; 318: 151–7PubMedCrossRef
26.
go back to reference Alonso J, Garcia-Miguel P, Abelairas J, et al. A microsatellite fluorescent method for linkage analysis in familial retinoblastoma and deletion detection at the RB1 locus in retinoblastoma and osteosarcoma. Diag Mol Pathol 2001; 10: 9–14CrossRef Alonso J, Garcia-Miguel P, Abelairas J, et al. A microsatellite fluorescent method for linkage analysis in familial retinoblastoma and deletion detection at the RB1 locus in retinoblastoma and osteosarcoma. Diag Mol Pathol 2001; 10: 9–14CrossRef
27.
go back to reference Sellner LN, Edkins E, Smith N. Screening for RBI mutations in tumour tissue using denaturing high performance liquid chromatography, multiplex ligation-dependent probe amplification, and loss of heterozygosity analysis. Pediatr Dev Pathol 2006; 9: 31–7PubMedCrossRef Sellner LN, Edkins E, Smith N. Screening for RBI mutations in tumour tissue using denaturing high performance liquid chromatography, multiplex ligation-dependent probe amplification, and loss of heterozygosity analysis. Pediatr Dev Pathol 2006; 9: 31–7PubMedCrossRef
Metadata
Title
RB1 Germ-Line Deletions in Argentine Retinoblastoma Patients
Authors
Cecilia Fernández
Karina Repetto
Viviana Dalamon
Fenanda Bergonzi
Veronica Ferreiro
Dr Irene Szijan
Publication date
01-01-2007
Publisher
Springer International Publishing
Published in
Molecular Diagnosis & Therapy / Issue 1/2007
Print ISSN: 1177-1062
Electronic ISSN: 1179-2000
DOI
https://doi.org/10.1007/BF03256222

Other articles of this Issue 1/2007

Molecular Diagnosis & Therapy 1/2007 Go to the issue

Original Research Article

Retinoblastoma in India

Technical Resource

The BiolAD-DB System

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.